Oculaire Ophthalmic Ventures Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-12-2024
- Paid Up Capital ₹ 0.90 M
as on 28-12-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 85.48%
(FY 2022)
- Profit 107.99%
(FY 2022)
- Ebitda 1000.42%
(FY 2022)
- Net Worth 7.53%
(FY 2022)
- Total Assets 21.93%
(FY 2022)
About Oculaire Ophthalmic Ventures
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Manojkumar Chandrasekhar and Sreedevi Chandran serve as directors at the Company.
- CIN/LLPIN
U33110KL2010PTC027133
- Company No.
027133
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oculaire Ophthalmic Ventures?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manojkumar Chandrasekhar  | Managing Director | 03-Dec-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreedevi Chandran | Director | 03-Dec-2011 | Current |
Financial Performance of Oculaire Ophthalmic Ventures.
Oculaire Ophthalmic Ventures Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 85.48% increase. The company also saw a substantial improvement in profitability, with a 107.99% increase in profit. The company's net worth moved up by a moderate rise of 7.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oculaire Ophthalmic Ventures?
In 2020, Oculaire Ophthalmic Ventures had a promoter holding of 94.44% and a public holding of 5.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Talent Scan Educational Services Private LimitedActive 23 years 6 monthsManojkumar Chandrasekhar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oculaire Ophthalmic Ventures?
Unlock and access historical data on people associated with Oculaire Ophthalmic Ventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oculaire Ophthalmic Ventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oculaire Ophthalmic Ventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
